ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 97 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125 | -18.3% | 18,684 | +2.7% | 0.00% | – |
| Q2 2023 | $153 | -84.7% | 18,200 | +4818.9% | 0.00% | – |
| Q2 2022 | $1,000 | -99.3% | 370 | -98.9% | 0.00% | – |
| Q1 2022 | $143,000 | +10.9% | 32,203 | 0.0% | 0.00% | – |
| Q4 2021 | $129,000 | -54.6% | 32,203 | -0.4% | 0.00% | – |
| Q3 2021 | $284,000 | -39.6% | 32,332 | -22.1% | 0.00% | – |
| Q2 2021 | $470,000 | +993.0% | 41,500 | +135.8% | 0.00% | – |
| Q1 2020 | $43,000 | -57.8% | 17,600 | 0.0% | 0.00% | – |
| Q4 2019 | $102,000 | +9.7% | 17,600 | 0.0% | 0.00% | – |
| Q3 2019 | $93,000 | -12.3% | 17,600 | 0.0% | 0.00% | – |
| Q2 2019 | $106,000 | -33.3% | 17,600 | 0.0% | 0.00% | – |
| Q1 2019 | $159,000 | +8.9% | 17,600 | 0.0% | 0.00% | – |
| Q4 2018 | $146,000 | -39.9% | 17,600 | 0.0% | 0.00% | – |
| Q3 2018 | $243,000 | +73.6% | 17,600 | 0.0% | 0.00% | – |
| Q2 2018 | $140,000 | – | 17,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 473,446 | $5,625,000 | 4.61% |
| Knoll Capital Management, LLC | 569,405 | $6,765,000 | 4.41% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 321,879 | $3,824,000 | 2.09% |
| First Light Asset Management, LLC | 2,624,001 | $31,173,000 | 2.07% |
| Mesirow Financial Investment Management, Inc. | 63,634 | $756,000 | 2.06% |
| Ghost Tree Capital, LLC | 650,000 | $7,722,000 | 1.82% |
| Altium Capital Management LP | 548,225 | $6,513,000 | 1.81% |
| Perceptive Advisors | 8,703,879 | $103,402,000 | 1.31% |
| Affinity Asset Advisors, LLC | 300,000 | $3,564,000 | 1.21% |
| Avidity Partners Management LP | 2,552,000 | $30,318,000 | 0.84% |